Novel treatments for celiac disease: Glutenases and beyond

Digestive Diseases

Volumn 33, Issue 2, 2015, Pages 277-281

  Kaukinen, Katri ^a,b   Lindfors, Katri ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Celiac disease; Enzyme supplement; Gluten; Glutenase; Villous atrophy

Indexed keywords

GLUTEN; GLUTENASE; LATIGLUTENASE; PROLAMIN; PROLYL ENDOPROTEASE; PROTEINASE; SERINE PROTEINASE; UNCLASSIFIED DRUG; PEPTIDE HYDROLASE;

ARTICLE; ASPERGILLUS NIGER; CELIAC DISEASE; CEREAL; DIGESTION; ENZYME THERAPY; GLUTEN FREE DIET; HUMAN; LAMINA PROPRIA; PRIORITY JOURNAL; SUPPLEMENTATION; WHEAT; ANIMAL; CLINICAL TRIAL (TOPIC); DRUG SCREENING;

ANIMALS; CELIAC DISEASE; CLINICAL TRIALS AS TOPIC; DRUG EVALUATION, PRECLINICAL; HUMANS; PEPTIDE HYDROLASES;

EID: 84930005592     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000369536     Document Type: Article

References (33)

1. Ludvigsson JF, Bai JC, Biagi F, Card TR, Ciacci C, Ciclitira PJ, Green PH, Hadjivassiliou M, Holdoway A, van Heel DA, Kaukinen K, Leffler DA, Leonard JN, Lundin KE, McGough N, Davidson M, Murray JA, Swift GL, Walker MM, Zingone F, Sanders DS: BSG Coeliac Disease Guidelines Development Group: Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut 2014; 63: 1210-1228.
2. Lee AR, Ng DL, Zivin J, Green PH: Economic burden of a gluten-free diet. J Hum Nutr Diet 2007; 20: 423-430.
3. Shah S, Akbari M, Vanga R, Kelly CP, Hansen J, Theethira T, Tariq S, Dennis M, Leffler DA: Patient perception of treatment burden is high in celiac disease compared with other common conditions. Am J Gastroenterol DOI: 10.1038/ajg.2014.29.
4. Hall NJ, Rubin G, Charnock A: Systematic review: adherence to a gluten-free diet in adult patients with coeliac disease. Aliment Pharmacol Ther 2009; 30: 315-330.
5. Ilus T, Lähdeaho MT, Salmi T, Haimila K, Partanen J, Saavalainen P, Huhtala H, Mäki M, Collin P, Kaukinen K: Persistent duodenal intraepithelial lymphocytosis despite a longterm strict gluten-free diet in celiac disease. Am J Gastroenterol 2012; 107: 1563-1569.
6. Leffler DA, Dennis M, Hyett B, Kelly E, Schuppan D, Kelly CP: Etiologies and predictors of diagnosis in nonresponsive celiac disease. Clin Gastroenterol Hepatol 2007; 5: 445-450.
7. Collin P, Thorell L, Kaukinen K, Mäki M: The safe threshold for gluten contamination in gluten-free products. Can trace amounts be accepted in the treatment of coeliac disease? Aliment Pharmacol Ther 2004; 19: 1277-1283.
8. Wild D, Robins GG, Burley VJ, Howdle PD: Evidence of high sugar intake, and low fibre and mineral intake, in the gluten-free diet. Aliment Pharmacol Ther 2010; 32: 573-581.
9. Aziz I, Evans KE, Papageorgiou V, Sanders DS: Are patients with coeliac disease seeking alternative therapies to a gluten-free diet? J Gastrointest Liver Dis 2011; 20: 27-31.
10. Ukkola A, Mäki M, Kurppa K, Collin P, Huhtala H, Kekkonen L, Kaukinen K: Patients' experiences and perceptions of living with coeliac disease-implications for optimizing care. J Gastrointest Liver Dis 2012; 21: 17-22.
11. van Overbeek FM, Uil-Dieterman IG, Mol IW, Köhler-Brands L, Heymans HS, Mulder CJ: The daily gluten intake in relatives of patients with coeliac disease compared with that of the general Dutch population. Eur J Gastroenterol Hepatol 1997; 9: 1097-1099.
12. Shan L, Molberg Ø, Parrot I, Hausch F, Filiz F, Gray GM, Sollid LM, Khosla C: Structural basis for gluten intolerance in celiac sprue. Science 2002; 297: 2275-2279.
13. Abadie V, Sollid LM, Barreiro LB, Jabri B: Integration of genetic and immunological insights into a model of celiac disease pathogenesis. Annu Rev Immunol 2011; 29: 493-525.
14. De Angelis M, Cassone A, Rizzello CG, Gagliardi F, Minervini F, Calasso M, Di Cagno R, Francavilla R, Gobbetti M: Mechanism of degradation of immunogenic gluten epitopes from Triticum turgidum L. var. durum by sourdough lactobacilli and fungal proteases. Appl Environ Microbiol 2010; 76: 508-518.
15. Di Cagno R, Barbato M, Di Camillo C, Rizzello CG, De Angelis M, Giuliani G, De Vincenzi M, Gobbetti M, Cucchiara S: Glutenfree sourdough wheat baked goods appear safe for young celiac patients: a pilot study. J Pediatr Gastroenterol Nutr 2010; 51: 777-783.
16. Greco L, Gobbetti M, Auricchio R, Di Mase R, Landolfo F, Paparo F, Di Cagno R, De Angelis M, Rizzello CG, Cassone A, Terrone G, Timpone L, D'Aniello M, Maglio M, Troncone R, Auricchio S: Safety for patients with celiac disease of baked goods made of wheat flour hydrolyzed during food processing. Clin Gastroenterol Hepatol 2011; 9: 24-29.
17. Kaukinen K, Lindfors K, Mäki M: Advances in the treatment of coeliac disease: an immunopathogenic perspective. Nat Rev Gastroenterol Hepatol 2014; 11: 36-44.
18. Bethune MT, Strop P, Tang Y, Sollid LM, Khosla C: Heterologous expression, purification, refolding, and structural-functional characterization of EP-B2, a self-activating barley cysteine endoprotease. Chem Biol 2006; 13: 637-647.
19. Siegel M, Bethune MT, Gass J, Ehren J, Xia J, Johannsen A, Stuge TB, Gray GM, Lee PP, Khosla C: Rational design of combination enzyme therapy for celiac sprue. Chem Biol 2006; 13: 649-658.
20. Stepniak D, Spaenij-Dekking L, Mitea C, Moester M, de Ru A, Baak-Pablo R, van Veelen P, Edens L, Koning F: Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease. Am J Physiol Gastrointest Liver Physiol 2006; 291:G621-G629.
21. Matysiak-Budnik T, Candahl C, Collier C, Dugave C, Namane A, Vidal-Martinez, Cerf-Bensussan N, Heyman M: Limited efficiency of prolyl-endopeptidase in the detoxification of gliadin peptides in celiac disease. Gastroenterology 2005; 129: 786-796.
22. Gass J, Vora H, Bethune MT, Gray GM, Khosla CJ: Effect of barley endoprotease EP-B2 on gluten digestion in the intact rat. Pharmacol Exp Ther 2006; 318: 1178-1186.
23. Gass J, Bethune MT, Siegel M, Spencer A, Khosla C: Combination enzyme therapy for gastric digestion of dietary gluten in patients with celiac sprue. Gastroenterology 2007; 133: 472-480.
24. Bethune MT, Ribka E, Khosla C, Sestak K: Transepithelial transport and enzymatic detoxification of gluten in gluten-sensitive rhesus macaques. PLoS One 2008; 3:e1857.
25. Mitea C, Havenaar R, Drijfhout JW, Edens L, Dekking L, Koning F: Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: implications for coeliac disease. Gut 2008; 57: 25-32.
26. Stenman SM, Venäläinen JI, Lindfors K, Auriola S, Mauriala T, Kaukovirta-Norja A, Jantunen A, Laurila K, Qiao SW, Sollid LM, Männisto PT, Kaukinen K, Mäki M: Enzymatic detoxification of gluten by germinating wheat proteases: implications for new treatment of celiac disease. Ann Med 2009; 41: 390-400.
27. Stenman SM, Lindfors K, Venäläinen JI, Hautala A, Männistö PT, Garcia-Horsman JA, Kaukovirta-Norja A, Auriola S, Mauriala T, Mäki M, Kaukinen K: Degradation of coeliac disease-inducing rye secalin by germinating cereal enzymes: diminishing toxic effects in intestinal epithelial cells. Clin Exp Immunol 2010; 161: 242-249.
28. Toft-Hansen H, Rasmussen KS, Staal A, Roggen EL, Sollid LM, Lillevang ST, Barington T, Husby S: Treatment of both native and deamidated gluten peptides with an endo-peptidase from Aspergillus niger prevents stimulation of gut-derived gluten-reactive T cells from either children or adults with celiac disease. Clin Immunol 2014; 153: 323-331.
29. Pyle GG, Paaso B, Anderson BE, Allen DD, Marti T, Li Q, Siegel M, Khosla C, Gray GM: Effect of pretreatment of food gluten with prolyl endopeptidase on gluten-induced malabsorption in celiac sprue. Clin Gastroenterol Hepatol 2005; 3: 687-694.
30. Tye-Din JA, Anderson RP, Ffrench RA, Brown GJ, Hodsman P, Siegel M, Botwick W, Shreeniwas R: The effects of ALV003 pre-digestion of gluten on immune response and symptoms in celiac disease in vivo. Clin Immunol 2010; 134: 289-295.
31. Tack GJ, van de Water JM, Bruins MJ, Kooy-Winkelaar EM, van Bergen J, Bonnet P, Vreugdenhil AC, Korponay-Szabo I, Edens L, von Blomberg BM, Schreurs MW, Mulder CJ, Koning F: Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study. World J Gastroenterol 2013; 19: 5837-5847.
32. Lähdeaho ML, Kaukinen K, Laurila K, Vuotikka P, Koivurova OP, Kärjä-Lahdensuu T, Marcantonio A, Adelman DC, Mäki M: Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease. Gastroenterology 2014; 146: 1649-1658.
33. Siegel M, Garber ME, Spencer AG, Botwick W, Kumar P, Williams RN, Kozuka K, Shreeniwas R, Pratha V, Adelman DC: Safety, tolerability, and activity of ALV003: results from two phase 1 single, escalating-dose clinical trials. Dig Dis Sci 2012; 57: 440-450.